5129-23-7

Usage

Uses

Used in Pharmaceutical Industry:
3-AMINO-4-ETHYLBENZOIC ACID is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its presence in the molecular structure of certain compounds can enhance their therapeutic effects.
Used in Dye and Pigment Industry:
3-AMINO-4-ETHYLBENZOIC ACID is used as a chemical intermediate for the production of dyes and pigments, where its unique molecular structure can influence color properties and stability.
Used in Medicine:
3-AMINO-4-ETHYLBENZOIC ACID is used as a building block in medicine for its potential to be incorporated into the structure of pharmaceutical compounds, thereby contributing to the creation of new therapeutic agents.
Used in Biochemistry Research:
3-AMINO-4-ETHYLBENZOIC ACID is used in biochemistry for its potential applications in the study of biological processes, given its pharmacological properties and its capacity to be a part of complex organic molecules.
Used in Antimicrobial Applications:
3-AMINO-4-ETHYLBENZOIC ACID has been studied for its potential antimicrobial properties, making it a candidate for use in the development of new antimicrobial agents to combat resistant strains of bacteria.
Used in Antioxidant Formulations:
3-AMINO-4-ETHYLBENZOIC ACID is considered for use in antioxidant formulations due to its potential antioxidant properties, which could be beneficial in various industrial applications where protection against oxidative damage is required.

InChI:InChI=1/C9H11NO2/c1-2-6-3-4-7(9(11)12)5-8(6)10/h3-5H,2,10H2,1H3,(H,11,12)

Upstream product

• 619-64-7 p-ethylbenzoic acid 
• 156098-55-4 3-nitro-4-vinylbenzoic acid 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 103440-95-5 4-Ethyl-3-nitrobenzoic acid 

Downstream Products

• 201286-96-6 3-methyl-indazole-6-carboxylic acid 
• 1415481-78-5 (2R,3R)-4-(2-Chlorophenyl)-3-[4-ethyl-3-(6-methyl-2,4-dioxo-1,4-dihydro-2H-thieno[2,3-d]pyrimidin-3-yl)-benzoylamino]-2-hydroxy-butyric Acid 
• 1449514-93-5 4-ethyl-N,N-dimethyl-3-(1-methyl-1H-imidazo[ 4,5-c]pyridin-6-ylamino)benzamide 
• 1369892-98-7 3-amino-4-ethyl-N,N-dimethylbenzamide 
• 1449664-59-8 4-ethyl-N,N-dimethyl-3-(methyl(1-methyl-1H-imidazo[4,5-c]pyridin-6-yl)amino)benzamide 
• 219763-47-0 6-carboxy-1-(2,4-dichlorobenzyl)-3-methyl-1H-indazole 
• 219764-07-5 6-carboxy-1-(2-chloro-4-phenylbenzyl)-3-methyl-1H-indazole 

Relevant academic research and scientific papers

BENZAMIDE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER

The present invention is directed to benzamide derivatives, pharmaceutical compositions containing them, and their use as FASN inhibitors, in for example, the treatment of cancer, obesity related disorders, liver related disorders and viral infections. Such compounds are represented by formula (I) as follows: wherein R1, R2, R3, R4, R5, m, n, (II) and (III) are defined herein.

IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, wherein R1 and Cy are as disclosed herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Wherein R1, L1, R3, R4, Cy, L2 and R5 are as defined herein. Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.

Sulfonamide compounds and medicinal use thereof

A sulfonamide compound of the formula (I):R 1 --SO 2 NHCO--A--R 2 (I)wherein R 1 is alkyl, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R 2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.